According to the Immunisation Coalition it is advised to undergo annual vaccination before the commencement of each influenza season.
While the protection is generally effective throughout the season, the optimal defense against influenza is achieved within the initial 3 to 4 months post-vaccination. The next flu season will be here before we know it, so it’s crucial to remember that we cannot guarantee the availability of stock for in-season purchases. Pre-season ordering is the optimal choice to ensure an ample supply of vaccines for your patients.
Products available for the 2025 Influenza Season
Egg-Based Vaccine
FluQuadri® can be
administered to adults and children aged 6 months
and above.
Egg-Based Vaccine
Afluria® Quad can be administered to adults and children aged 5 years
and above.
Cell-Based Vaccine
Flucelvax® Quad can be administered to adults and children aged 2 years
and above.
CREATE A WORLD FULL OF GIVING WITH US
At Team Medical, every action counts towards making a difference. When you purchase your influenza vaccines from us in 2025, you’re not just protecting your patients – you’re also supporting meaningful causes worldwide.
For every dose of vaccine purchased, we’re committed to providing one day of clean water through projects like borehole construction in Africa. This initiative is part of our partnership with B1G1 – Business for Good, ensuring that our efforts transcend profits to focus on people and purpose.
Our mission goes beyond business success – it’s about creating sustainable lifestyles and making a real difference in communities, both near and far. By choosing Team Medical, you’re contributing to local vaccination efforts and empowering communities overseas with access to clean water.
Together, let’s build a future where every action counts towards a world full of giving.
2025 State Influenza Programs
NSW
No State-Based Programs have been announced.
TAS
No State-Based Programs have been announced.
QLD
All Queensland residents aged six months and older will be eligible to receive a free flu vaccine in 2025. Vaccine providers are to order their vaccines from their regular supplier. A fixed reimbursement fee of $25.00 will be provided for each privately purchased and administered vaccine given to non-NIP eligible people during the program.
WA
No State-Based Programs have been announced.
SA
No State-Based Programs have been announced.
NT
No State-Based Programs have been announced.
ACT
No State-Based Programs have been announced.
VIC
No State-Based Programs have been announced.
2025 Influenza Vaccine Composition
The Australian Influenza Vaccine Committee (AIVC) met to recommend the composition of the influenza virus vaccines for Australia in 2025. At this meeting, the expert committee reviewed and evaluated epidemiology, antigenic and genetic data of recent influenza isolates circulating in Australia and the southern hemisphere. Serological responses to the 2023-2024 vaccines, and the availability of candidate vaccines viruses and reagents were also reviewed by the Committee.
The Committee recommended the following viruses for vaccines used in the 2025 southern hemisphere trivalent influenza vaccines in Australia:
Egg-based quadrivalent influenza vaccines:
- an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
- an A/Croatia/10136RV/2023 (H3N2)-like virus; and
- a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.
Cell- or recombinant-based quadrivalent influenza vaccines:
- an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
- an A//District of Columbia/27/2023 (H3N2)-like virus; and
- a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.
The recommendation for the B/Yamagata lineage component of quadrivalent influenza vaccines remains unchanged from previous recommendations:
- a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.
Transition from Quadrivalent to Trivalent Seasonal Influenza Vaccines in Australia
Australia is transitioning from using quadrivalent influenza vaccine (QIV) to trivalent influenza vaccine (TIV) formulations for influenza immunisation in our population. During the transition period, ATAGI supports the use of either QIV or TIV. During the transition from QIV to TIV, Australia will ensure that the supply of vaccine is adequate and secure. It is possible that some TIV formulations may become available in 2025 to be used alongside QIV, which will continue to be available. It is anticipated that TIV may be used exclusively by the 2026 influenza season.
Read MoreDon't Delay - Order Today!
Why pre-ordering with Team Medical is a smart choice?
- Priority allocation of stock and delivery of stock
- All orders are processed following our strict cold chain procedures
- We will deliver what you need when you need it
- Our team has over 20 years experience supplying Influenza vaccines
- We have fulfilled every pre-season order placed over the past 12 years
- Consistency of supply
We have fulfilled 100% of 2024 pre-season orders.
Secure your stock with the team that delivers.
Happy Team Medical Customer
Our commitment to providing excellent service is never more evident than during flu season where our entire team kicks into overdrive. below is what one our customers had to say about our influenza partnership.
“The service that comes with your Influenza program is exceptional. We know there are many other customers, but we feel like we’re at the top of the list. We’ve never had a cold chain issue, but I know if we had, you would replace what’s needed and afterwards, we would work out the behind-the-scenes stuff. If we don’t have what we need, we can’t support our patients.”
Correct Storage and Transport is Paramount.
Because, even one broken link in the chain can mean your vaccines aren't viable.
At Team Medical, we adhere to the 'Strive for 5' National Vaccine Storage Guidelines. Below is a snapshot of what we do to ensure your vaccines
are kept at the correct temperature from the moment we receive the stock to when the stock is delivered.
Complete
Coolroom Processing
By picking and packing every order inside our purpose-built coolrooms, we ensure the required temperature range (between 2-8°C) is continually maintained.
Heat & Freeze Monitors
in Every Order
An alarm is triggered if your vaccines get too hot or too cold. For vaccine storage and transport compliance, a freeze monitor is a non-negotiable. Vaccines are damaged once frozen, always check your Heat & Freeze Monitor.
Shipped in Eskies
or in Validated Cold Trucks
In available regions, we ship vaccine orders with Mediport's validated refrigeration vehicles. All other vaccine orders are shipped in eskies following strict procedures.
24-Hour Monitoring
and Backup Power
Our coolrooms are monitored 24 hours a day using back-to-base data loggers. We have generators on all sites to provide backup power when power outages occur.
Door-to-Door
Delivery Tracking
Our dedicated staff track, trace and verify every cold chain delivery, every day. Consignments are checked to ensure arrival at key destination depots.
Complete
Coolroom Processing
By picking and packing every order inside our purpose-built coolrooms, we ensure the required temperature range (between 2-8°C) is continually maintained.